NEW YORK (GenomeWeb) – Rennova Health said today that it has acquired the 85 percent stake in pharmacogenetics testing firm Genomas that it did not already own.

Hartford, Connecticut-based Genomas has developed and offers the PhyzioType System for DNA-guided management and prescription of drugs used to treat mental illness, pain, heart disease and diabetes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.